• Corpus ID: 74401049

Missing data in randomised controlled trials: a practical guide

  title={Missing data in randomised controlled trials: a practical guide},
  author={Carpenter and Michael G. Kenward},
Objective: Missing data are ubiquitous in clinical trials, yet recent research suggests many statisticians and investigators appear uncertain how to handle them. The objective is to set out a principled approach for handling missing data in clinical trials, and provide examples and code to facilitate its adoption. Data sources: An asthma trial from GlaxoSmithKline, a asthma trial from AstraZeneca, and a dental pain trial from GlaxoSmithKline. Methods: Part I gives a non-technical review how… 

Strategies for Dealing with Missing Data in Clinical Trials: From Design to Analysis

This review aims to convey an appreciation for how missing data influences results and an understanding of the need for careful consideration of missing data during the design, planning, conduct, and analytic stages.

Practical and statistical issues in missing data for longitudinal patient-reported outcomes

This paper considers the issues of missing data at each stage of research, and the importance of sensitivity analyses, including the role of missing not at random models, such as pattern mixture, selection, and shared parameter models.

Sensitivity analysis for clinical trials with missing continuous outcome data using controlled multiple imputation: A practical guide

This tutorial provides an overview of controlled multiple imputation techniques and a practical guide to their use for sensitivity analysis of trials with missing continuous outcome data, including δ- and reference-based MI procedures.

Handling of missing data in long‐term clinical trials: a case study

Missing data in clinical trials is a well‐known problem, and the classical statistical methods used can be overly simple. This case study shows how well‐established missing data theory can be applied

A review of the use of controlled multiple imputation in randomised controlled trials with missing outcome data

Controlled MI enabled the impact of accessible contextually relevant missing data assumptions to be examined on trial results and there is a need for improved reporting on the implementation of MI analyses and choice of controlled MI parameters.

Missing data in clinical trials: from clinical assumptions to statistical analysis using pattern mixture models

Several strategies for missing data on the basis of pattern mixture models that embody clear and realistic clinical assumptions are explored, which provide a statistically reasonable yet transparent framework for translating clinical assumptions into statistical analyses.

A general method for handling missing binary outcome data in randomized controlled trials

A new method for undertaking sensitivity analyses when handling missing data in trials with binary outcomes allows a wide range of assumptions about the missing data to be assessed and in two smoking cessation trials the results were insensitive to all but extreme assumptions.

Cost-effectiveness analysis with informative missing data: tools and strategies

This PhD thesis critically assessed the statistical methods for handling MNAR data in CEA practice, and identified barriers to more widespread use of these methods, via a systematic review and stakeholder focus groups.

A four-step strategy for handling missing outcome data in randomised trials affected by a pandemic

A four-step strategy for handling missing outcome data in the analysis of randomised trials that are ongoing during a pandemic is presented and controlled multiple imputation is highlighted as an accessible tool for conducting sensitivity analyses.



Coping with missing data in clinical trials: A model‐based approach applied to asthma trials

A class of models for modelling both the response to treatment and the drop-out process are proposed, and the use of a time transformation to linearize an asymptotic pattern of repeated measures over time is proposed to simplify the modelling.

Analyzing incomplete longitudinal clinical trial data.

It is argued that some simple but commonly used methods to handle incomplete longitudinal clinical trial data require restrictive assumptions and stand on a weaker theoretical foundation than likelihood-based methods developed under the missing at random (MAR) framework, and their optimal place is within sensitivity analysis.

Eliciting and using expert opinions about dropout bias in randomized controlled trials

A practical, accessible, approach that allows expert opinions about the degree of departure from missing at random in the analysis of a clinical trial to be meaningfully and accurately elicited and incorporated in sensitivity analysis and can claim to be a truly conservative method.

Intent-to-treat analysis for longitudinal studies with drop-outs.

This work proposes a method that involves multiple imputation of the missing values following drop-out based on an "as treated" model, using actual dose after drop- out if this is known, or imputed doses that incorporate a variety of plausible alternative assumptions if unknown.

Adjusting for partially missing baseline measurements in randomized trials

Joint modelling of baseline and outcome is the most efficient method, subject to three conditions, and a dummy variable for missingness should be included as a covariate (the missing indicator method).

A critical look at methods for handling missing covariates in epidemiologic regression analyses.

The authors recommend that epidemiologists avoid using the missing-indicator method and use more sophisticated methods whenever a large proportion of data are missing, and contrast the results of multiple imputation to simple methods in the analysis of a case-control study of endometrial cancer.

Clinical trials in psychiatry: should protocol deviation censor patient data?

  • P. Lavori
  • Psychology, Medicine
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
  • 1992
The context of clinical experimentation in psychiatry is reviewed, the state of design and analysis with expert recommendations on general methods are compared, the current statistical strategies are reviewed and it is proposed that investigators should try to obtain complete follow-up data on all patients without regard to their adherence to treatment protocol.

What is meant by intention to treat analysis? Survey of published randomised controlled trials

Assessment of reports of randomised controlled trials published in 1997 found that intention to treat was used, but handling of deviations from randomised allocation varied widely and methods used to deal with this were generally inadequate, potentially leading to bias.

Multiple Imputation in Practice : Comparison of Software Packages for Regression Models With Missing Variables

A number of software packages that implement multiple imputation, originally proposed by Rubin in a public use dataset setting, are described and evaluated, and the interface, features, and results are compared.